Pfizer removes HALF of patients from its Lyme disease vaccine trial

Around 3,500 patients will be pulled from the Phase III study due to violations of Good Clinical Practice (GCP) rules, which refer to ethical and scientific standards for clinical trials.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news